Otologic and vestibular symptoms in COVID-19: A scoping review.

Kimberly Mae C Ong, Teresa Luisa G Cruz
{"title":"Otologic and vestibular symptoms in COVID-19: A scoping review.","authors":"Kimberly Mae C Ong, Teresa Luisa G Cruz","doi":"10.1002/wjo2.57","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Otologic and vestibular symptoms have been seen in patients confirmed to have COVID-19 disease. Further discussion of these symptoms may provide insight into short- and long-term management for these patients.</p><p><strong>Objective: </strong>The aim of this review was to describe the otologic and vestibular symptoms that present in patients with COVID-19. The primary outcomes of this review were onset, duration and clinical outcomes of these symptoms.</p><p><strong>Sources of evidence: </strong>Pub Med, APAMed Central, Herdin, CINAHL, Scopus, Springer Link, ProQuest Coronavirus Research Database, and Google Scholar were searched for the articles to be included.</p><p><strong>Eligibility criteria: </strong>Studies included were those involving adult patients diagnosed with COVID-19 who experienced hearing loss, ear pain, ear discharge, otitis media, vertigo, or tinnitus. Studies were eligible for inclusion if there was a description of the otologic dysfunction, specifically onset, duration, or clinical outcomes.</p><p><strong>Results: </strong>The majority of patients who experienced hearing loss (68%), tinnitus (88%), vertigo/dizziness (30%), ear pain (8%), and discharge (100%) did so within a month of experiencing the typical symptoms of COVID-19. A majority also experienced complete resolution of their symptoms within 2 weeks. Standard treatment for COVID-19 was usually provided but when specific diagnoses are made for these symptoms (e.g., sudden sensorineural hearing loss, otitis media, vestibular neuritis), they are treated in the same manner as one would for non-COVID-19 cases, in addition to the management for COVID-19. In certain cases, there may be a need for additional work-up to rule out other causes.</p><p><strong>Conclusions: </strong>Otologic and vestibular symptoms were present in COVID-19 patients, majority as part of the systemic nature of the disease. The onset, duration, and course were consistent with the natural history of a systemic viral infection. COVID-19 should be considered in any patient with a new-onset hearing loss, tinnitus, or vertigo/dizziness, even in the absence of infectious or respiratory symptoms.</p>","PeriodicalId":32097,"journal":{"name":"World Journal of OtorhinolaryngologyHead and Neck Surgery","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-04-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/07/03/WJO2-8-287.PMC9111077.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of OtorhinolaryngologyHead and Neck Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/wjo2.57","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Otologic and vestibular symptoms have been seen in patients confirmed to have COVID-19 disease. Further discussion of these symptoms may provide insight into short- and long-term management for these patients.

Objective: The aim of this review was to describe the otologic and vestibular symptoms that present in patients with COVID-19. The primary outcomes of this review were onset, duration and clinical outcomes of these symptoms.

Sources of evidence: Pub Med, APAMed Central, Herdin, CINAHL, Scopus, Springer Link, ProQuest Coronavirus Research Database, and Google Scholar were searched for the articles to be included.

Eligibility criteria: Studies included were those involving adult patients diagnosed with COVID-19 who experienced hearing loss, ear pain, ear discharge, otitis media, vertigo, or tinnitus. Studies were eligible for inclusion if there was a description of the otologic dysfunction, specifically onset, duration, or clinical outcomes.

Results: The majority of patients who experienced hearing loss (68%), tinnitus (88%), vertigo/dizziness (30%), ear pain (8%), and discharge (100%) did so within a month of experiencing the typical symptoms of COVID-19. A majority also experienced complete resolution of their symptoms within 2 weeks. Standard treatment for COVID-19 was usually provided but when specific diagnoses are made for these symptoms (e.g., sudden sensorineural hearing loss, otitis media, vestibular neuritis), they are treated in the same manner as one would for non-COVID-19 cases, in addition to the management for COVID-19. In certain cases, there may be a need for additional work-up to rule out other causes.

Conclusions: Otologic and vestibular symptoms were present in COVID-19 patients, majority as part of the systemic nature of the disease. The onset, duration, and course were consistent with the natural history of a systemic viral infection. COVID-19 should be considered in any patient with a new-onset hearing loss, tinnitus, or vertigo/dizziness, even in the absence of infectious or respiratory symptoms.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
COVID-19 中的耳部和前庭症状:范围综述。
背景:在确诊患有 COVID-19 疾病的患者中出现了耳部和前庭症状。对这些症状的进一步讨论可为这些患者的短期和长期治疗提供见解:本综述旨在描述 COVID-19 患者的耳科和前庭症状。本综述的主要结果是这些症状的发病、持续时间和临床结果:对Pub Med、APAMed Central、Herdin、CINAHL、Scopus、Springer Link、ProQuest Coronavirus Research Database和Google Scholar进行了检索,以纳入相关文章:所纳入的研究均涉及确诊感染 COVID-19 并出现听力损失、耳痛、耳流脓、中耳炎、眩晕或耳鸣的成年患者。如果研究描述了耳科功能障碍,特别是发病、持续时间或临床结果,则符合纳入条件:结果:大多数患者在出现 COVID-19 典型症状后一个月内出现听力下降(68%)、耳鸣(88%)、眩晕/头晕(30%)、耳痛(8%)和分泌物增多(100%)等症状。大多数患者的症状也在两周内完全消失。通常会对 COVID-19 进行标准治疗,但当对这些症状(如突发性感音神经性听力损失、中耳炎、前庭神经炎)做出具体诊断时,除了对 COVID-19 进行治疗外,还会以治疗非 COVID-19 病例的相同方式对其进行治疗。在某些情况下,可能需要进行额外的检查以排除其他病因:结论:COVID-19 患者出现耳部和前庭症状,大多数是该病全身性质的一部分。其发病、持续时间和病程与全身性病毒感染的自然病史一致。任何新发听力损失、耳鸣或眩晕/头晕的患者,即使没有感染或呼吸道症状,也应考虑 COVID-19。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
4.10
自引率
0.00%
发文量
283
审稿时长
13 weeks
期刊最新文献
Author Guidelines. Author Guidelines. Long COVID: From olfactory dysfunctions to viral Parkinsonism. Author Guidelines. Epidemiological and histopathological characteristics of thyroid carcinoma in a Tunisian health care center.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1